SynthesisProstate cancer and prostatic diseases2020

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.

Keiichiro Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.